RT Journal Article
SR Electronic
T1 Vaccine Effectiveness for the COVID-19 in Japan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.20.21259209
DO 10.1101/2021.06.20.21259209
A1 Kurita, Junko
A1 Sugawara, Tamie
A1 Ohkusa, Yasushi
YR 2021
UL http://medrxiv.org/content/early/2021/10/22/2021.06.20.21259209.abstract
AB Background As of the end of September, 2021, the rate of completion for second dose administration was higher than 55% in Japan.Object We evaluated vaccine effectiveness for COVID-19 in Japan, controlling mutated strains, the Olympic Games and counter measures.Method The effective reproduction number R(t) was regressed on vaccine coverage, shares of mutated strains, and an Olympic Games dummy variable along with data of temperature, humidity, mobility, and countermeasures. The study period was February, 2020 through September 28, as of October 18, 2021.Results Estimation results indicate that vaccine coverage reduced R(t) significantly. The infectiousness of mutated strain N501Y decreased significantly, but that of L452R was not significant. The Olympic Games did not affect infectiousness significantly.Discussion and Conclusion Results indicate a negative association between infectiousness and vaccine coverage. Moreover, some evidence exists of herd immunity attributable to vaccination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All information used for this study has been published. There is therefore no ethical issue related to this study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases.(in Japanese) https://www.mhlw.go.jp/stf/newpage_10723.html